FDA Inspection 1305912 - Saptalis Pharmaceuticals LLC - March 06, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Saptalis Pharmaceuticals LLC, with an inspection on March 6, 2026, issued by the New York District Office, covering human drugs.

Company: Saptalis Pharmaceuticals LLC
Inspection Date: March 6, 2026
Product Type: Human Drugs
Office: New York District Office

Open in Dashboard

ID · 110d88c7-f70f-498e-9269-9b842cc13af6

Violation Codes1

21 CFR 211.63

Full citation text and observation details available on the Dashboard.